Does BENRALIZUMAB Cause Malignant neoplasm progression? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Malignant neoplasm progression have been filed in association with BENRALIZUMAB (FASENRA). This represents 0.1% of all adverse event reports for BENRALIZUMAB.
10
Reports of Malignant neoplasm progression with BENRALIZUMAB
0.1%
of all BENRALIZUMAB reports
3
Deaths
2
Hospitalizations
How Dangerous Is Malignant neoplasm progression From BENRALIZUMAB?
Of the 10 reports, 3 (30.0%) resulted in death, 2 (20.0%) required hospitalization, and 1 (10.0%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BENRALIZUMAB. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does BENRALIZUMAB Cause?
Asthma (2,457)
Dyspnoea (1,604)
Death (1,336)
Drug ineffective (1,266)
Cough (793)
Headache (788)
Product dose omission issue (713)
Pneumonia (710)
Wheezing (619)
Malaise (514)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which BENRALIZUMAB Alternatives Have Lower Malignant neoplasm progression Risk?
BENRALIZUMAB vs BENSERAZIDE
BENRALIZUMAB vs BENSERAZIDE\LEVODOPA
BENRALIZUMAB vs BENZALKONIUM
BENRALIZUMAB vs BENZOCAINE
BENRALIZUMAB vs BENZODIAZEPINE